Across TCGA pan-cancer cohorts, FAM207CP RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of FAM207CP’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where FAM207CP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FAM207CP is over-expressed in tumor.
KIRC are the cancer types where FAM207CP tumor–normal differential expression is most reproducible.